Furthermore, we observed a significant enrichment of the Rgs2+CD8+ T cell subset in tumor tissues following the combined treatment, which consisted of a large proportion of neoantigen‐specific T cells and was closely associated with the therapeutic efficacy. Here, CD8A is linked to neoplasm.